|
Stockholders' Equity (Narrative) (Details) (USD $)
|
12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2011
|
Feb. 29, 2012
Private Placement [Member]
|
Dec. 31, 2013
Private Placement [Member]
|
Feb. 29, 2012
Placemenet Agent [Member]
|
Dec. 31, 2013
Restricted Stock [Member]
|
Dec. 31, 2012
Restricted Stock [Member]
|
Dec. 31, 2013
2006 Plan [Member]
|
Apr. 13, 2006
2006 Plan [Member]
|
Dec. 31, 2013
2010 Plan [Member]
|
Dec. 30, 2012
2010 Plan [Member]
|
Dec. 31, 2013
Exercise Price, $35.00 to $98.90 [Member]
|
Jun. 28, 2012
Banks.com [Member]
|
Apr. 02, 2012
Theorem Capital, LLC [Member]
|
Dec. 31, 2013
Minimum [Member]
Exercise Price, $35.00 to $98.90 [Member]
|
Dec. 31, 2013
Maximum [Member]
Exercise Price, $35.00 to $98.90 [Member]
|
|
| Stockholders' Equity [Line Items] | |||||||||||||||||
| Common stock, shares issued | 10,979,372 | 7,113,744 | 944,777 | ||||||||||||||
| Cash received from issuance of common stock and warrants | $ 4,250,000 | ||||||||||||||||
| Warrants Term | 5 years 6 months | 3 years | |||||||||||||||
| Warrants Duration Not Exercisable After Issuance | 6 months | ||||||||||||||||
| Warrants to acquire shares of common stock | 30,000 | 236,194 | 35,429 | ||||||||||||||
| Warrants to acquire shares of common stock, exercise price | $ 6.81 | $ 7.46 | $ 35.00 | $ 98.90 | |||||||||||||
| Warrant expiration | 2017 | ||||||||||||||||
| Placement agent fee, percentage | 7.00% | ||||||||||||||||
| Placement agent fee | 300,000 | ||||||||||||||||
| Stock issuance costs | 100,000 | ||||||||||||||||
| Fair value of warrants | 769,284 | 277,646 | |||||||||||||||
| Quoted price per share used to calculate fair value | $ 3.40 | ||||||||||||||||
| Issue shares of common stock to the shareholders of Banks.com | 702,267 | ||||||||||||||||
| Common shares issued in connection with cashless exercise of warrants | 32,405 | ||||||||||||||||
| Number of shares available to purchase from warrant | 65,359 | ||||||||||||||||
| Share authorized | 800,000 | 525,000 | |||||||||||||||
| Fair value of grants | 324,601 | 241,927 | |||||||||||||||
| Vesting period | 3 years 6 months | ||||||||||||||||
| Stock options, grant date fair value | $ 2.58 | $ 4.60 | |||||||||||||||
| Stock-based compensation expense | 600,000 | 800,000 | 400,000 | 300,000 | |||||||||||||
| Unrecognized compensation expense | 1,100,000 | 600,000 | |||||||||||||||
| Number of options, Exercised | 0 | ||||||||||||||||
| Maximum term | 10 years | ||||||||||||||||
| Fair value of options vested | 300,000 | 200,000 | |||||||||||||||
| Grant date fair value of options | 100,000 | 700,000 | |||||||||||||||
| Shares available for issuance | 279,329 | ||||||||||||||||
| Fair value of restricted stock vested | $ 800,000 | $ 400,000 | |||||||||||||||